Pre-transfusion tests include ABO and RhD typing of the patient's red blood cells and an antibody screen with the patient's plasma. The latter is a method to detect clinically significant non-ABO antibodies to red cell antigens
Answer:
The patient’s progress will increase because a variety of treatments are being used.
Explanation:
Answer:
About 70%, about 110% is the correct answer.
Explanation:
